COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,479,272 | -41.3% | 395,527 | -33.0% | 0.00% | -100.0% |
Q2 2023 | $2,519,506 | -34.3% | 590,048 | +5.2% | 0.00% | 0.0% |
Q1 2023 | $3,836,556 | -16.4% | 560,900 | -3.2% | 0.00% | 0.0% |
Q4 2022 | $4,588,911 | -23.5% | 579,408 | -7.1% | 0.00% | 0.0% |
Q3 2022 | $5,996,000 | +43.0% | 623,891 | +7.7% | 0.00% | 0.0% |
Q2 2022 | $4,194,000 | -45.6% | 579,311 | -3.0% | 0.00% | 0.0% |
Q1 2022 | $7,708,000 | -31.9% | 597,045 | -15.8% | 0.00% | -50.0% |
Q4 2021 | $11,320,000 | -13.5% | 709,284 | -12.9% | 0.00% | -33.3% |
Q3 2021 | $13,086,000 | +19.6% | 814,371 | +2.9% | 0.00% | +50.0% |
Q2 2021 | $10,941,000 | -9.7% | 791,099 | -4.6% | 0.00% | 0.0% |
Q1 2021 | $12,120,000 | -15.4% | 829,625 | +0.7% | 0.00% | -33.3% |
Q4 2020 | $14,325,000 | +10.0% | 824,236 | +16.1% | 0.00% | 0.0% |
Q3 2020 | $13,024,000 | +3.4% | 710,166 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $12,595,000 | +180.4% | 705,156 | +154.6% | 0.00% | +200.0% |
Q1 2020 | $4,492,000 | -10.4% | 276,946 | -0.5% | 0.00% | 0.0% |
Q4 2019 | $5,012,000 | -9.3% | 278,371 | +2.1% | 0.00% | -50.0% |
Q3 2019 | $5,525,000 | -20.8% | 272,739 | -13.6% | 0.00% | 0.0% |
Q2 2019 | $6,974,000 | +127.6% | 315,554 | +40.4% | 0.00% | +100.0% |
Q1 2019 | $3,064,000 | +52.2% | 224,698 | +1.0% | 0.00% | 0.0% |
Q4 2018 | $2,013,000 | -42.9% | 222,542 | +4.1% | 0.00% | 0.0% |
Q3 2018 | $3,527,000 | +35.2% | 213,776 | +14.8% | 0.00% | 0.0% |
Q2 2018 | $2,608,000 | +33.4% | 186,287 | +5.3% | 0.00% | 0.0% |
Q1 2018 | $1,955,000 | +33.9% | 176,988 | +6.7% | 0.00% | – |
Q4 2017 | $1,460,000 | -37.0% | 165,923 | -4.4% | 0.00% | -100.0% |
Q3 2017 | $2,317,000 | -4.9% | 173,541 | +2.2% | 0.00% | 0.0% |
Q2 2017 | $2,437,000 | -30.2% | 169,840 | +2.8% | 0.00% | 0.0% |
Q1 2017 | $3,492,000 | -11.4% | 165,140 | +17.9% | 0.00% | 0.0% |
Q4 2016 | $3,942,000 | +9.7% | 140,032 | +4.4% | 0.00% | 0.0% |
Q3 2016 | $3,592,000 | +54.3% | 134,127 | -2.7% | 0.00% | 0.0% |
Q2 2016 | $2,328,000 | +8.3% | 137,857 | +36.2% | 0.00% | 0.0% |
Q1 2016 | $2,149,000 | +12.9% | 101,207 | +22.0% | 0.00% | 0.0% |
Q4 2015 | $1,904,000 | +12.5% | 82,935 | -1.8% | 0.00% | 0.0% |
Q3 2015 | $1,693,000 | -38.3% | 84,482 | -11.0% | 0.00% | 0.0% |
Q2 2015 | $2,743,000 | +57.8% | 94,909 | +67.0% | 0.00% | – |
Q1 2015 | $1,738,000 | +536.6% | 56,825 | +239.2% | 0.00% | – |
Q4 2014 | $273,000 | – | 16,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |